Trombocitemia essencial. Terapêutica com alfa interferão.

A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative...

Full description

Bibliographic Details
Main Authors: L Lebre, A Sousa, J Sampaio, L Novais, E Júnior, R Coelho, J Simões
Format: Article
Language:English
Published: Ordem dos Médicos 1991-08-01
Series:Acta Médica Portuguesa
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3353
_version_ 1797996240622845952
author L Lebre
A Sousa
J Sampaio
L Novais
E Júnior
R Coelho
J Simões
author_facet L Lebre
A Sousa
J Sampaio
L Novais
E Júnior
R Coelho
J Simões
author_sort L Lebre
collection DOAJ
description A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.
first_indexed 2024-04-11T10:14:35Z
format Article
id doaj.art-daaef0270acb46bdb7ade2ca41f20e90
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-11T10:14:35Z
publishDate 1991-08-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-daaef0270acb46bdb7ade2ca41f20e902022-12-22T04:30:00ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07581991-08-014410.20344/amp.3353Trombocitemia essencial. Terapêutica com alfa interferão.L Lebre0A SousaJ SampaioL NovaisE JúniorR CoelhoJ SimõesServiço de Medicina Interna, Hospital Sa. Cruz, Carnaxide.A clinical case of essential thrombocythaemia is presented to demonstrate good therapeutic response to subcutaneous Alpha-2b Interferon in a dosage of 3 x 10(6) units, three times a week. Based on this case and on a literature research we propose that Alpha-2b Interferon is a legitimate alternative to alkylating agents or radioactive phosphorus (32P), showing identical efficacy and less Leukemogen effect.https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3353
spellingShingle L Lebre
A Sousa
J Sampaio
L Novais
E Júnior
R Coelho
J Simões
Trombocitemia essencial. Terapêutica com alfa interferão.
Acta Médica Portuguesa
title Trombocitemia essencial. Terapêutica com alfa interferão.
title_full Trombocitemia essencial. Terapêutica com alfa interferão.
title_fullStr Trombocitemia essencial. Terapêutica com alfa interferão.
title_full_unstemmed Trombocitemia essencial. Terapêutica com alfa interferão.
title_short Trombocitemia essencial. Terapêutica com alfa interferão.
title_sort trombocitemia essencial terapeutica com alfa interferao
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/3353
work_keys_str_mv AT llebre trombocitemiaessencialterapeuticacomalfainterferao
AT asousa trombocitemiaessencialterapeuticacomalfainterferao
AT jsampaio trombocitemiaessencialterapeuticacomalfainterferao
AT lnovais trombocitemiaessencialterapeuticacomalfainterferao
AT ejunior trombocitemiaessencialterapeuticacomalfainterferao
AT rcoelho trombocitemiaessencialterapeuticacomalfainterferao
AT jsimoes trombocitemiaessencialterapeuticacomalfainterferao